Cravings: Engineered to Want More

GLP-1 exposed the core design flaw in modern food. It lowered the artificial salt and sugar intensity that more than 70% of the US packaged food supply depends on, much of it built around amplified salt and sugar to create flavor, and once that intensity quieted, the products built on it stopped tasting good.

That is the actual mechanism behind the category declines. Not appetite suppression. Not a shift toward wellness. A loss of the amplification that made these foods desirable.

Starting in the 1980s, the industry systematically applied what food scientists came to call the Bliss Point: the precise calibration of salt, sugar, and fat to keep consumers eating past the point of genuine satiation. The industry operationalized it at scale. The result was a food supply engineered not to satisfy but to sustain the craving for the next unit.

The Cornell University and Numerator study, published in the Journal of Marketing Research in December 2024, tracked grocery expenditures across 2,623 GLP-1 households drawn from a 22,712-household panel, six months before and after adoption. Overall spend dropped 5.3%. The declines were not spread evenly.

Savory snacks fell approximately 10%. Sweets, baked goods, and cookies followed. Yogurt, fresh fruit, nutrition bars, and meat snacks held or grew.

Research presented at the European Association for the Study of Diabetes Annual Meeting in 2025 found that roughly one in five users on semaglutide or tirzepatide reported heightened intensity of sweet and salty tastes after starting the medication. When that amplification increased, single-note products did not become more appealing. They became harder to finish. The salt hit on a chip calibrated for a quieter palate becomes overwhelming on a sensitized one. The Cornell spend data confirms the behavioral outcome: the categories built on amplified signal contracted. The categories built on genuine sensory structure held.

A chip without the salt hit is starch. A cookie without the sugar is flour. Once the amplification dropped, the products built on it had nothing left to offer.

GLP-1 users are not a perfect proxy for the entire market. They are a leading indicator of what happens when engineered signal is interrupted. Private label sales hit a record $271 billion in 2024, growing nearly four times faster than national brands, per PLMA citing Circana data. Price drove consumers there first. Quality retention is what kept them. The GLP-1 cohort is the leading edge of a broader consumer recalibration already visible in the aggregate data.

The most instructive data point is what happened after people stopped the medication.

Most grocery spending returned to baseline. Candy and chocolate did not. Post-discontinuation spending on candy and chocolate landed 11.4% above pre-medication levels, per the Cornell and Numerator study. The instinct is to read that as rebound eating: months of restriction followed by overcorrection. That explanation is plausible. It does not account for where the overshoot landed.

Trade reporting citing Circana purchasing data found that better-quality chocolate sales among GLP-1 users grew nearly 17% in 2025, compared to 6.5% among non-users. The trading-up gap between GLP-1 users and non-users was nearly three times wider. Even if some portion of the overshoot reflects compensatory behavior, the direction matters. These consumers were not reaching for more sugar after restriction. They were reaching for better. Less volume, higher quality, stronger willingness to pay per occasion.

When the signal came back, it came back wanting something real. That is a unit economics shift, not a dietary one.

The consensus response is reformulation. More protein. Less sugar. Cleaner labels.

That is not the wrong direction. It is not a sufficient one.

FMI research finds 77% of shoppers actively making healthier food choices. What healthy means in practice has changed. It is no longer a label claim. It is a sensory standard: I want to feel better after I eat. That bar does not go back down once the consumer has cleared it. The industry cannot out-market that shift. It has to out-flavor it.

A high-protein snack built on a single engineered note has the same structural problem as the chip it replaced. Nutritional improvement does not rebuild the signal. A consumer who has experienced genuine satiety is not retained by a macronutrient profile. Reformulation optimizes the label and the shelf. It does not rebuild the repeat purchase mechanism.

This is where the commodity trap and the craving story converge. The brands that added protein to existing architectures are competing on a claim. The brands that built sensory complexity into the product from the beginning are competing on something no retailer can replicate at a lower price point.

The products holding position share a sensory architecture that single-note engineering has always struggled to replicate: acidity that brightens, fermentation that adds depth, umami that builds rather than peaks and fades.

These are not finishing details. They are the architecture of repeat purchase.

A sliver of aged Parmesan demonstrates the mechanism in ten seconds. Salt registers first. Then fat. Then the umami builds, sustained primarily by glutamate and inosinate working in combination. Then it finishes, and the consumer does not reach for another piece because the flavor already completed the job. Multiple compounds, one ingredient, a finish that signals satiety rather than demanding continuation. Processed food built on a single engineered note was not designed to replicate that. It was designed to replace the need for it. GLP-1 exposed the limits of that replacement.

The same architecture shows up across the brands holding margin. Bachan’s layers soy, mirin, and ginger so the flavor evolves rather than repeats. A properly made kimchi delivers heat, acid, fermentation depth, and umami in sequence. None of these are trend plays. They are products with sensory architecture that gives the consumer a reason to come back that has nothing to do with engineered craving.

For manufacturers, acidity balance, fermentation depth, and textural contrast are now structural inputs, not differentiation options. A product that reveals something new on the fifth occasion earns its place in the basket. A product with one loud note, however clean the label, does not.

For brand builders, the credibility signal has shifted from health claims and ingredient lists to sensory specificity: how it tastes, what it does on the palate, and why it is worth coming back to.